Hims Hers Health Inc (HIMS)
Who owns Hims Hers Health Inc (HIMS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.4% of the shares are freely tradable; institutional investors hold 70.0%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 11.38 | 26,337,158 | -0.9 | 03/31/2026 |
| Vanguard Group Inc | 9.04 | 20,925,666 | +7.2 | 12/31/2025 |
| Vanguard Portfolio Management, LLC | 4.40 | 10,183,813 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.04 | 9,339,711 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 3.84 | 8,889,088 | +126.2 | 03/31/2026 |
| State Street Corp | 3.22 | 7,460,023 | +2.1 | 03/31/2026 |
| Defiance ETFs, LLC | 3.21 | 7,424,258 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 2.26 | 5,240,816 | -72.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.05 | 7,066,722 | +0.0 | 05/29/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.88 | 6,658,910 | +0.2 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Jul 2026 | Okupe Oluyemi | Chief Financial Officer | Sell | 7,163 | 31.99 | 229,168 |
| 17. Jul 2026 | Okupe Oluyemi | Chief Financial Officer | Other | 7,163 | 5.01 | 35,887 |
| 20. Apr 2026 | Oluyemi Okupe | CFO | Sell | 19,645 | 29.96 | 588,564 |
| 20. Apr 2026 | Soleil Boughton | Insider | Sell | 9,463 | 30.00 | 283,890 |
| 17. Apr 2026 | Oluyemi Okupe | CFO | Sell | 18,005 | 27.83 | 501,079 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.